98 related articles for article (PubMed ID: 9147713)
21. Clinical and pharmacokinetic study of fractionated doses of oral etoposide in pediatric patients with advanced malignancies.
Gregianin LJ; Brunetto AL; Di Leone L; Costa TD; Santos PP; Schwartsmann G
Med Sci Monit; 2002 Sep; 8(9):PI70-7. PubMed ID: 12218955
[TBL] [Abstract][Full Text] [Related]
22. Vasopressin modulation of peritoneal, lymphatic, and plasma drug exposure following intraperitoneal administration.
Lindnér P; Heath D; Howell S; Naredi P; Hafström L
Clin Cancer Res; 1996 Feb; 2(2):311-7. PubMed ID: 9816174
[TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetics of carboplatin and etoposide in a haemodialysis patient with Merkel-cell carcinoma.
Suzuki S; Koide M; Sakamoto S; Matsuo T
Nephrol Dial Transplant; 1997 Jan; 12(1):137-40. PubMed ID: 9027788
[TBL] [Abstract][Full Text] [Related]
24. Correct carboplatin dose?
Loughner J
Arch Otolaryngol Head Neck Surg; 2003 Dec; 129(12):1351; author reply 1351. PubMed ID: 14676171
[No Abstract] [Full Text] [Related]
25. A case of mixed adult Wilms' tumour and angiosarcoma responsive to carboplatin, etoposide and vincristine (CEO).
Yau T; Leong CH; Chan WK; Chan JK; Liang RH; Epstein RJ
Cancer Chemother Pharmacol; 2008 Apr; 61(4):717-20. PubMed ID: 17571263
[TBL] [Abstract][Full Text] [Related]
26. Effects of morin on the pharmacokinetics of etoposide in rats.
Li X; Yun JK; Choi JS
Biopharm Drug Dispos; 2007 Apr; 28(3):151-6. PubMed ID: 17315145
[TBL] [Abstract][Full Text] [Related]
27. Carboplatin/paclitaxel versus cisplatin/paclitaxel as first-line chemotherapy in advanced ovarian cancer: an interim analysis of a randomized phase III trial of the Arbeitsgemeinschaft Gynäkologische Onkologie Ovarian Cancer Study Group.
du Bois A; Lück HJ; Meier W; Möbus V; Costa S; Richter B; Warm M; Bauknecht T; Schröder W; Olbricht S; Nitz U; Jackisch C
Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-44-S15-52. PubMed ID: 9346222
[TBL] [Abstract][Full Text] [Related]
28. [Peripheral blood stem cell collection in pediatric malignancies: comparison between three mobilizing regimens].
De Pasquale MD; Cacchione A; Foco M; Gozzer M; Libera F; Soscia F; Ragni G; Cappelli C
Clin Ter; 2003; 154(5):305-9. PubMed ID: 14994920
[TBL] [Abstract][Full Text] [Related]
29. Paclitaxel in salvage therapy for germ cell tumors.
Motzer RJ
Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-83-S15-85. PubMed ID: 9346229
[TBL] [Abstract][Full Text] [Related]
30. [Pharmacokinetics and individual dose adjustment of carboplatin].
Chatelut E; Canal P; Bugat R
Bull Cancer; 2000 Aug; 87 Spec No():17-23. PubMed ID: 11082718
[TBL] [Abstract][Full Text] [Related]
31. Population pharmacokinetics of etoposide: application to therapeutic drug monitoring.
Ciccolini J; Monjanel-Mouterde S; Bun SS; Blanc C; Duffaud F; Favre R; Durand A
Ther Drug Monit; 2002 Dec; 24(6):709-14. PubMed ID: 12451286
[TBL] [Abstract][Full Text] [Related]
32. Validation of a limited sampling model to determine etoposide area under the curve.
Lum BL; Lane KJ; Synold TW; Goram A; Charnick SB; Sikic BI
Pharmacotherapy; 1997; 17(5):887-90. PubMed ID: 9324178
[TBL] [Abstract][Full Text] [Related]
33. Carboplatin equals cisplatin: but how do I prescribe it?
Gore M
J Clin Oncol; 2003 Sep; 21(17):3183-5. PubMed ID: 12860965
[No Abstract] [Full Text] [Related]
34. [Salvage thermochemotherapy in advanced refractory malignant tumors in children].
Ismail-zade RS; Buglova SE; Potapnev MP; Sachivko NV; Semenov AS; Rud'ko VS; Shman TV; Zhavrid EA
Vopr Onkol; 2002; 48(3):351-5. PubMed ID: 12455361
[TBL] [Abstract][Full Text] [Related]
35. Hepatic artery administration of paclitaxel.
Walton GD; Schreeder MT; Rizzo J; Jobe DR; Kuhn J
Cancer Invest; 1999; 17(2):118-20. PubMed ID: 10071596
[No Abstract] [Full Text] [Related]
36. [Radio-chemotherapy combination in locally advanced, inoperable, non-small cell bronchial cancers].
Mornex F
Rev Pneumol Clin; 2002 Nov; 58(5 Pt 2):3S37-41. PubMed ID: 12538934
[No Abstract] [Full Text] [Related]
37. Carbon nanotubes enhance the internalization of drugs by cancer cells and decrease their chemoresistance to cytostatics.
Mahmood M; Xu Y; Dantuluri V; Mustafa T; Zhang Y; Karmakar A; Casciano D; Ali S; Biris A
Nanotechnology; 2013 Feb; 24(4):045102. PubMed ID: 23291321
[TBL] [Abstract][Full Text] [Related]
38. Enhanced bioavailability of etoposide after oral or intravenous administration of etoposide with kaempferol in rats.
Li C; Li X; Choi JS
Arch Pharm Res; 2009 Jan; 32(1):133-8. PubMed ID: 19183886
[TBL] [Abstract][Full Text] [Related]
39. Effect of grapefruit juice intake on etoposide bioavailability.
Reif S; Nicolson MC; Bisset D; Reid M; Kloft C; Jaehde U; McLeod HL
Eur J Clin Pharmacol; 2002 Oct; 58(7):491-4. PubMed ID: 12389073
[TBL] [Abstract][Full Text] [Related]
40. Clinical pharmacology of chronic oral etoposide in patients with small cell and non-small cell lung cancer.
Zucchetti M; Pagani O; Torri V; Sessa C; D'Incalci M; De Fusco M; de Jong J; Gentili D; Martinelli G; Tinazzi A
Clin Cancer Res; 1995 Dec; 1(12):1517-24. PubMed ID: 9815952
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
